Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Daizo Kaito"'
Autor:
Hidenori Mori, Chizuru Sakai, Masamichi Iwai, Yuka Sasaki, Takenobu Gomyo, Sayaka Toyoshi, Daizo Kaito, Komei Yanase, Fumitaka Ito, Junki Endo, Norihiko Funaguchi, Yasushi Ohno, Shinya Minatoguchi
Publikováno v:
Respiratory Medicine Case Reports, Vol 28, Iss , Pp - (2019)
Antibodies targeting the receptor programmed death 1 on T cells have been approved for the treatment of lung cancer. Immune checkpoint inhibitors (ICIs) induce various immune-related adverse events. Life-threatening hematotoxicity can be provoked by
Externí odkaz:
https://doaj.org/article/06f6e3ed5b1e48f3a6b95a9663510d75
Autor:
Fumitaka Ito, Yasushi Ohno, Sayaka Toyoshi, Daizo Kaito, Yanase Koumei, Junki Endo, Fumihiko Kamamiya, Hidenori Mori, Masahiro Mori, Megumi Morishita, Norihiko Funaguchi, Shinya Minatoguchi
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 10 (2016)
A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxacin (400 mg) following a once-daily oral administration in 28 patients with respiratory tract infection disease. The maximum plasma concentration and
Externí odkaz:
https://doaj.org/article/43a863213d9a499899995d535107762a
Autor:
MOTOHIKO KINOMURA, HIROTOSHI IIHARA, HIRONORI FUJII, CHIEMI HIROSE, JUNKI ENDO, KOMEI YANASE, TOSHIYA INUI, DAIZO KAITO, YUKA SASAKI, TAKENOBU GOMYO, CHIZURU SAKAI-MASUDA, DAISUKE KAWAE, YU KITAMURA, MASACHIKA FUKUI, RYO KOBAYASHI, YASUSHI OHNO, AKIO SUZUKI
Publikováno v:
Anticancer Research. 43:1301-1307
Autor:
Daizo Kaito, Mototsugu Shimokawa, Takenobu Gomyo, Jun Hakamata, Akio Suzuki, Takahiro Arai, Yasushi Ohno, Chiemi Hirose, Norihiko Funaguchi, Chizuru Sakai, Hitoshi Kawazoe, Koichi Minato, Hiroyuki Okura, Hisao Imai, Hirotoshi Iihara, Yukiyoshi Fujita, Shinnosuke Ikemura, Mie Kotake
Publikováno v:
The Oncologist
Background Olanzapine is an inexpensive and durable agent for the treatment of chemotherapy‐induced nausea and vomiting and is also superior to neurokinin‐1 receptor antagonists in the control of nausea. This study aimed to investigate the effica
Autor:
Hironori, Fujii, Ayumu, Araki, Hirotoshi, Iihara, Daizo, Kaito, Chiemi, Hirose, Motohiko, Kinomura, Mizuki, Yamazaki, Junki, Endo, Toshiya, Inui, Komei, Yanase, Yuka, Sasaki, Takenobu, Gomyo, Chizuru, Sakai, Daisuke, Kawae, Yu, Kitamura, Masachika, Fukui, Ryo, Kobayashi, Yasushi, Ohno, Akio, Suzuki
Publikováno v:
Molecular and Clinical Oncology. 16
Pembrolizumab, either as a type of monotherapy or in combination with cytotoxic anticancer agents, is effective in the treatment of advanced non-small cell lung cancer (NSCLC). However, the development of cancer cachexia may adversely affect anticanc
Autor:
Norihiko, Funaguchi, Hirotoshi, Iihara, Daizo, Kaito, Takenori, Gomyo, Yuka, Sasaki, Komei, Yanase, Junki, Endo, Fumitaka, Ito, Chiemi, Hirose, Yasushi, Ohno, Hiroyuki, Okura
Publikováno v:
Mol Clin Oncol
Although co-administration of cisplatin (CDDP) and vinorelbine (VNR) has been established as a standard of care adjuvant chemotherapy for non-small cell lung cancer (NSCLC), there is a lack of clinical data on its safety and efficacy in Japanese pati
Autor:
Jun Hakamata, Hiroyuki Okura, Yukiyoshi Fujita, Chizuru Sakai, Shinnosuke Ikemura, Takenobu Gomyo, Koichi Minato, Yasushi Ohno, Hisao Imai, Chiemi Hirose, Daizo Kaito, Mototsugu Shimokawa, Hitoshi Kawazoe, Takahiro Arai, Norihiko Funaguchi, Hirotoshi Iihara, Akio Suzuki, Mie Kotake
Publikováno v:
Lung cancer.
Autor:
Yasushi Ohno, Chiemi Hirose, Hirotoshi Iihara, Komei Yanase, Daizo Kaito, Norihiko Funaguchi, Akio Suzuki, Fumitaka Ito, Junki Endo
Publikováno v:
Mol Clin Oncol
Due to the increasing complexity of cancer chemotherapy and its associated supportive care, the role of clinical pharmacists in cancer chemotherapy is becoming increasingly more important. The present study evaluated the clinical interventions of a s
Autor:
Chizuru Sakai, Daizo Kaito, Mototsugu Shimokawa, Koichi Minato, Hiroyuki Okura, Chiemi Hirose, Takenobu Gomyo, Hirotoshi Iihara, Y. Ohno, Yuka Fujita, Hisao Imai, Akio Suzuki, T. Arai, Hitoshi Kawazoe, Mie Kotake, Norihiko Funaguchi, Jun Hakamata, S. Ikemura
Publikováno v:
Annals of Oncology. 32:S1175-S1176
Autor:
Yoshinori Itoh, Yuka Sasaki, Daizo Kaito, Komei Yanase, Natsumi Arai, Hirotoshi Iihara, Yasushi Ohno, Shinya Minatoguchi, Mika Kitahora, Chiemi Hirose, Fumitaka Ito, Sayaka Toyoshi, Norihiko Funaguchi, Junki Endo
Publikováno v:
Anticancer Research. 37:1965-1970
Background Carboplatin (CBDCA) is known to exhibit a high emetic risk among moderate-emetic risk anticancer drugs, and the dose of CBDCA varies in different therapies. In concurrent chemoradiotherapy (CCRT) for non-small cell lung cancer (NSCLC), the